Both Tirzepatide and the drug represent groundbreaking approaches to addressing blood sugar levels, and increasingly, obesity. Tirzepatide is a combined agonist that impacts multiple chemicals involved in blood sugar control: GLP-1 and GIP. Mounjaro, often seen as a product name for this compound